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Abstract: Asthma is a major burden on global health care system which is encumbering all regions in
the world. Several risk factors can induce and exacerbate asthma. Recent compelling evidences have
associated metabolic syndrome with the incidence of asthma. The abdominal obesity, hypertension
and insulin resistance are metabolic syndrome criteria which are substantially involved in inducing
and exacerbating asthma. Several mechanisms are involved in the association between metabolic
syndrome and asthma. It could be due to mechanical reason, genetic factors, inflammatory effect,
hormonal effect, insulin resistance and the effect of other co-morbidities associated with obesity. In
this review, we discuss the mechanisms which link metabolic syndrome to asthma.
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Introduction
Asthma is a major global health issue which burdens people from all regions of the world. It was estimated
that 334 million patients are suffering from asthma globally [1]. Using the Global Initiative for Asthma (GINA)
definition, asthma is a chronic and heterogeneous airway inflammatory disease with symptoms that vary in
time and intensity such as, wheeze, shortness of breath, chest tightness and cough [2]. Due to the airway hyper
responsiveness of asthma, the symptoms can be instigated by stimuli such as exercise, allergen, change in
weather or viral respiratory infection. An exacerbation of asthma may lead to long hospitalization and death.
Asthma can be exacerbated by several risk factors such as type two diabetes mellitus (T2-DM), obesity or high
body mass index (BMI), hypertension, gastroesophageal reflux and sleep-disorder breathing [3]. However, the
presence of clustering conditions such as, metabolic syndrome has strong association with asthma [4, 5]. Rather
than one disease, metabolic syndrome is a group of simultaneous disease conditions which include
hypertension, abdominal obesity (central obesity), atherogenic dyslipidemia and insulin resistance or glucose
intolerance [6]. According to the National Cholesterol Education Program’s Adult Treatment Panel III report
(NCEP ATP III), metabolic syndrome can be clinically diagnosed with the presence of at least three out of five
criteria which are waist circumference more than 40 inch in men and 35 inch in women, blood pressure more
than 130/85 mm Hg, fasting blood sugar more than 110 mg/dL, triglycerides (TG) more than 150 mg/dl and
high density lipoprotein (HDL) less than 40 mg/dL in men and 50mg/dL in women [7, 8]. In metabolic
syndrome, some types of cells suffer from function perturbation such as vascular endothelial cells, glandular
epithelium, renal epithelial cells and potentially the airway epithelial and sub epithelial cells [5]. Such
perturbations, make metabolic syndrome strong risk factor for cardiovascular diseases, stroke and diabetes.
Adding to them, growing evidences have strengthened the association between asthma and metabolic
syndrome [4, 9-11]. Here, we discuss the association of metabolic syndrome with asthma and the mechanisms
linking this association.
Metabolic syndrome associated asthma, where is the link?
The association between metabolic syndrome and asthma was investigated in several population studies. In in
the Korean health and genome study, the association between metabolic syndrome and asthma -like-symptoms
was tested among 9942 adults who were 40 to 69 years of age [12]. Among asthma-like-symptoms, wheeze
(p=0.0006), resting dyspnoea (p=0.0062) and post-exercise dyspnoea (p=0.0001) were significantly prevalent
among subjects with metabolic syndrome compared to subjects without metabolic syndrome. Among the
criteria of metabolic syndrome, abdominal obesity and elevated blood pressure were significantly associated
with asthma-like syndrome. The metabolic syndrome and incidence of asthma study (The HUNT study) was
one of the largest population based studies that asserted the association between metabolic syndrome and
asthma (adjusted OR 1.57, 95% CI 1.31 - 1.87) [4]. In this study, 23,191 asthma-free subjects were categorized
based on metabolic syndrome and followed-up for asthma incidence. Among metabolic syndrome components,
high waist circumference (adjusted OR 1.62, 95% CI 1.36–1.94) and elevated glucose or diabetes (adjusted
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OR 1.43, 95% CI 1.01–2.04) were significant. Furthermore, Assad et al (2013) indicated that asthma is
associated with three components of metabolic syndrome, the abdominal obesity, hypertension and elevated
fasting glucose or diabetes in an un-adjusted models [13]. However, upon adjusting the models to BMI, it was
found that BMI rather than metabolic syndrome is strongly associated with asthma in women. From the
aforementioned studies, it is understandable that the abdominal obesity, insulin resistance (elevated glucose)
and hypertension are the main risk factors that associate metabolic syndrome with asthma. Based on these risk
factors, there are several suggestive mechanisms which explain the link between metabolic syndrome and
asthma. It can be due to mechanical effect, genetic factors, epigenetic factors, inflammatory effect,
mitochondrial dysfunction, hormonal effect and the effect of other co-morbidities [5, 11, 14].
Abdominal obesity or visceral obesity component of the metabolic syndrome is actually a leading factor for
hypertension and insulin resistance [15, 16]. Therefore, visceral obesity plays pivotal role in the metabolic
syndrome-asthma linkage. This link is bilateral. Accordingly, obese asthmatic patients are more likely to
develop metabolic syndrome and vice versa [11]. The obesity associated asthma is distinctive phenotype of
asthma (OAA) and it is more likely to have poorer therapeutic outcome than non-obese asthmatic [9, 14]. This
appear in the mechanical, genetic, inflammatory and hormonal effects of obesity on asthma.
The mechanical effect of abdominal obesity on lung volumes is manifested in the exponential reduction of the
functional residual capacity (FRC) and the expiratory reserve volume (ERV) with the increase of BMI [17,
18]. In other words, an increase of BMI would cause an increase in airway resistance [18]. Obesity is associated
with several genetic variabilities that have substantial effect on asthma and its response to therapy. In fact,
asthma and obesity have shared genetic factors [14]. For instance, the β2-adrenergic receptor gene (ADRβ2)
and the glucocorticoid receptor gene (NR3C1) are related to asthma and obesity. The Gln27 polymorphism of
the ADRβ2 gene was found significantly more frequent among obese patients compared to non-obese [19].
This polymorphism interferes with the response to β2-agonists in asthma [20]. The polymorphism of the
NR3C1 gene was found to be significantly associated with bronchial asthma [14]. Besides, abdominal obesity
is highly affected by the genetic variation in glucocorticoid receptors [21]. Obesity is known to cause chronic
pro-inflammatory status in the human body which is characterized by the perturbation of pro-inflammatory
mediators [14]. The increased levels of high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor
alpha (TNF-α), interleukin (IL-6) and leptin were observed in obese-asthma patients [11, 14]. This pro-
inflammatory status can lead to airway modulation, insulin resistance and hypertension. Obese asthmatic
children had higher pro-inflammatory leptin and lower anti-inflammatory adiponectin compared to non-obese
asthmatic children [22]. The increase of leptin with the decrease of adiponectin has key role in airway
inflammation, lung dysfunction and the development of asthma [12, 23]. Besides, leptin can increase the levels
of other pro-inflammatory mediators such as TNF-α and IL-6 [11]. It is worthy to note that leptin can cause
renal and sympathetic effects leading to hypertension which is associated with asthma as well [12]. Hormonal-
differences has its implication on obesity linked asthma. Obesity reduces progesterone levels [24].
Progesterone causes up-regulation of ADRβ2 receptor. Moreover, leptin present in higher concentration in
women than men [14]. Thus, obese women are more likely to suffer from OAA than men.
Insulin resistance (glucose intolerance) a key element of metabolic syndrome leads to hyperinsulinemia which
is an increased level of insulin due to the elevated glucose levels [5]. Hyperinsulinemia is associated with
increased airway contractility, cell proliferation and fibrosis of the airway smooth muscle [25]. Indeed,
increased insulin activates the PI3K/Akt pathway in the bronchial epithelial cells which leads to
bronchoconstriction. Furthermore, metabolic syndrome is associated with increased asymmetric dimethyl
arginine (ADMA) which impairs the arginine-nitric oxide metabolism and cell programing [26]. This causes
an increase in arginine catabolism, as well as the formation of toxic reactive nitric oxide (peroxynitrite) which
cause bronchoconstriction and mitochondrial dysfunction. This impairment was found in both metabolic
syndrome and asthma as well.
In addition to all the aforementioned mechanisms that link metabolic syndrome with asthma, there are several
obesity related co-morbid conditions which can induce or exacerbate asthma condition such as sleep disorder
breathing (SDB), gastroesophageal reflux disease (GERD), T2-DM, hypertension and dyslipidemia [14]. The
SDB has been found significantly associated in asthma [27]. Similarly, GERD is associated with chest
congestion, lung inflammation and cough which may cause asthma and bronchitis [28]. The association
between hypertension and asthma is understandable with the effect of leptin on the renal and sympathetic
activity [12]. Elevated serum triglycerides and low HDL were associated with wheezing in large population
study of 85,555 Spanish adults [29]. T2-DM is highly associated with declined lung function [30]. Noteworthy,
the impaired arginine-nitric oxide metabolism and mitochondrial dysfunction which link metabolic syndrome
with asthma, are apparently manifested in T2-DM [31, 32].
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Conclusion
It could be concluded that the association between asthma and metabolic syndrome is supported by
growing body of evidences. This association is multifactorial rather than one direct linkage between
the two conditions. Asthmatic patients suffering from metabolic syndrome should not be treated for
asthma in isolation from their metabolic syndrome status to avoid poor therapeutic outcome.   A
personalized therapeutic regimen that includes weight management, asthma type phenotyping, as well
as drug response phenotyping may have better outcome.
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